Search research articles
Contact Us
Filters
Showing results (121-130 of 164) with videos related to
Page
of 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2015
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Robert Kridel, Luc Xerri, Bénédicte Gelas-Dore, et al.
Blood Advances
|
November 12, 2020
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, et al.
Ejhaem
|
August 13, 2025
A Pilot Collaborative Study to Improve the Diagnosis and Treatment of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in Senegal: The LYMPHODAK Study
Saliou Diop, Charline Moulin, Sokhna Aïssatou Touré, et al.
Haematologica
|
May 28, 2026
Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study
Julien Lazarovici, Sandy Amorim, Krimo Bouabdallah, et al.
Nature Communications
|
August 9, 2024
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
Romain Guièze, Loïc Ysebaert, Damien Roos-Weil, et al.
Blood
|
January 25, 2020
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, et al.
Blood Advances
|
January 9, 2026
Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphoma
Emilie Charton, Amélie Anota, Emmannuel Bachy, et al.
Nature Medicine
|
October 9, 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
Roch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
Lancet (London, England)
|
December 24, 2010
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
Gilles Salles, John Francis Seymour, Fritz Offner, et al.
The New England Journal of Medicine
|
September 28, 2017
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill, Catherine Thieblemont, Lucie Oberic, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 164) with videos related to
Sort By:
Page
of 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2015
The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association
Robert Kridel, Luc Xerri, Bénédicte Gelas-Dore, et al.
Blood Advances
|
November 12, 2020
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, et al.
Ejhaem
|
August 13, 2025
A Pilot Collaborative Study to Improve the Diagnosis and Treatment of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in Senegal: The LYMPHODAK Study
Saliou Diop, Charline Moulin, Sokhna Aïssatou Touré, et al.
Haematologica
|
May 28, 2026
Nivolumab with or without vinblastine for first-line treatment of elderly patients with Hodgkin lymphoma and coexisting medical conditions: the Niviniho phase II Lysa study
Julien Lazarovici, Sandy Amorim, Krimo Bouabdallah, et al.
Nature Communications
|
August 9, 2024
Blinatumomab after R-CHOP bridging therapy for patients with Richter transformation: a phase 2 multicentre trial
Romain Guièze, Loïc Ysebaert, Damien Roos-Weil, et al.
Blood
|
January 25, 2020
High total metabolic tumor volume at baseline predicts survival independent of response to therapy
Laetitia Vercellino, Anne-Segolene Cottereau, Olivier Casasnovas, et al.
Blood Advances
|
January 9, 2026
Health-related quality of life after second-line Axi-cel in transplant-ineligible patients with large B-cell lymphoma
Emilie Charton, Amélie Anota, Emmannuel Bachy, et al.
Nature Medicine
|
October 9, 2023
Publisher Correction: Axicabtagene ciloleucel as second-line therapy in large B cell lymphoma ineligible for autologous stem cell transplantation: a phase 2 trial
Roch Houot, Emmanuel Bachy, Guillaume Cartron, et al.
Lancet (London, England)
|
December 24, 2010
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
Gilles Salles, John Francis Seymour, Fritz Offner, et al.
The New England Journal of Medicine
|
September 28, 2017
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma
Steven Le Gouill, Catherine Thieblemont, Lucie Oberic, et al.
Page
of 17